| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8507778 | Acta Pharmaceutica Sinica B | 2018 | 8 Pages |
Abstract
Subcutaneously implanted sandwich poly(hydroxybutyrate-co-hydroxyhexanoate) (PHBHHx) films were proven to prolong release time and to inhibit burst release phenomenon of thymopentin (TP5). Pharmacodynamics analysis revealed that implantable sandwich films could achieve comparative or even superior therapeutic outcomes to TP5 everyday injection therapy.251
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Ke Peng, Chengyu Wu, Guoxu Wei, Jinghui Jiang, Zhirong Zhang, Xun Sun,